EL SALVADOR WILL RECEIVE VACCINES “AFTER VERIFYING THEIR LEVEL OF PREPAREDNESS AND RESPONSE TO THE PANDEMIC.”

We all know that Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with the COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. This virus became a Pandemic in 2020, one of the worst. The pandemic led to a very strong situation not only for El Salvador but also at the national level.

From the beginning of the pandemic, El Salvador managed to have a very good logistics team that was able to handle the situation in the most positive way for Salvadorans, the economy, and above all for health. All these facts have been supported by the World Health Organization, which has expressed itself very well during the course of this pandemic about the management and development of the pandemic. Today El Salvador maintains one of the lowest mortality rates in comparison to other countries, the economic situation is developing and the country can benefit from the good treatment and good management within the medical facilities of El Salvador, with the construction of the new project Hospital of El Salvador.

And although it has not been an easy process, El Salvador has a very well-known leader worldwide, our dearest Nayib Bukele, who has maximum effort and bet all his team to work in the best way so that El Salvador can get out of this pandemic as soon as possible.

Months and days passed and now El Salvador got another very good news thanks to the logistics and good management of the pandemic led by our president Nayib Bukele and all his team El Salvador will get the vaccine against covid-19 in the month of February.

This news is very encouraging, very gratifying, and not only do we have to thank our president  Nayib Bukele but also to all Salvadorans who have joined forces to move forward together as a team, have been strong and have been filled with courage to keep on going during this harsh pandemic. This extraordinary news will be a new investment for the development of the health of Salvadorans and also for the happiness and welfare of our entire nation.

https://diarioelsalvador.com/el-salvador-recibira-vacuna-del-mecanismo-covax-en-febrero/38024/

EL SALVADOR TO RECEIVE COVAX MECHANISM VACCINE IN FEBRUARY

The global COVAX Mechanism initiative that aims to ensure that all countries have rapid and equitable access to COVID-19 vaccines.

by Marbely Merino January 31, 2021 https://diarioelsalvador.com/

Six groups are priority for vaccination against COVID-19 in El Salvador.

El Salvador has been one of those selected for the first round of vaccine distribution through the COVAX mechanism, along with Bolivia, Colombia and Peru, which are the first four Latin American countries to receive the aid, according to a statement from the United Nations office in Bolivia.

According to the statement, the vaccines are expected to be distributed to the countries in February.

Previously, in November, the Government informed that all the steps had been taken at the highest level to enter the program, which was aimed at poor, emerging or developing countries to access the vaccine. They also detailed that the first people to be immunized are health personnel.

On January 6, the COVAX mechanism offered countries the opportunity to express their interest in accessing an initial limited volume of a Pfizer/BioNTech ultra-cold chain vaccine. There were 72 countries that submitted their proposal to receive the support.

“The urgent and equitable distribution of vaccines is not only a moral imperative, but also a strategic and economic imperative related to health security. The agreement with Pfizer will enable the COVAX Facility to save lives, stabilize health systems and boost global economic recovery,” said Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization.

The COVAX Mechanism is a global partnership for the procurement and equitable distribution of COVID-19 vaccines. It is led by the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi and the Pan American Health Organization (PAHO)/ World Health Organization (WHO), working in partnership with vaccine manufacturers, the United Nations Children’s Fund (UNICEF), the World Bank, civil society organizations and others. COVAX is one of the pillars of WHO’s comprehensive global plan to defeat the virus through the use of diagnostics, therapies and vaccines.

https://www.paho.org/es/noticias/31-1-2021-paises-americas-reciben-notificacion-sobre-asignacion-vacunas-contra-covid-19#:~:text=Los%20pa%C3%ADses%20y%20territorios%20de,%2C%20Granada%2C%20Guatemala%2C%20Guyana%2C

COUNTRIES IN THE AMERICAS RECEIVE NOTIFICATION OF COVID-19 VACCINE ALLOCATION THROUGH COVAX

31 Jan 2021

Vaccine Delivery Dates Announced for Countries Participating in COVAX

Washington, D.C., Jan. 31, 2021 (PAHO) – The Pan American Health Organization (PAHO) today announced that COVAX – a coalition led by WHO and Gavi to ensure equitable access to COVID-19 vaccines – has notified countries in the Americas of the estimated dose allocation for the first phase of COVID-19 vaccine delivery through a letter to their health authorities. Thirty-six countries and territories participating in COVAX received the letter, with information on the estimated number of doses of AstraZeneca’s vaccine that they could receive starting in the second half of February and throughout the second quarter of 2021.

AstraZeneca’s vaccine is still under review by WHO for emergency use approval (EUL), which is expected to occur in the next few days. The number of doses and delivery schedule are still subject to EUL, the ability to manufacture production, as well as the establishment of supply agreements between the producers, PAHO and UNICEF. According to the COVAX release, it is estimated that about 35.3 million doses will be arriving in the Americas in this first stage.

“With more than 45 million confirmed cases and more than one million deaths, countries and territories throughout the Americas, and particularly the poorest, are experiencing an unprecedented health, economic and social crisis,” said Dr. Carissa F. Etienne, director of PAHO.

The start of vaccine delivery through the COVAX mechanism is an encouraging step in the fight against this virus and PAHO is proud to facilitate an effort that is urgently needed in our region.

Dr. Carissa F. Etienne

The countries and territories of the Americas participating in the COVAX mechanism that received letters are: Antigua and Barbuda, Argentina, Bahamas, Barbados, Belize, Bermuda, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Dominica, Dominican Republic, Ecuador, El Salvador, St. Kitts and Nevis, Grenada, Guatemala, British Virgin Islands, Guyana, Haiti, Honduras, Jamaica, Mexico, Montserrat, Nicaragua, Panama, Paraguay, Peru, St. Vincent and the Grenadines, St. Lucia, Suriname, Trinidad and Tobago, Uruguay and Venezuela.

In anticipation of vaccine delivery, countries in the Americas participating in the COVAX mechanism began the process of preparing for the receipt and deployment of vaccines. With COVAX’s communication of the start of delivery of the first doses of vaccine, countries must ensure that they are ready to use the vaccines. PAHO provided technical assistance during the preparation phase.

Countries participating in the COVAX mechanism were also invited to submit proposals for the “First Wave” initiative, a global pilot program to receive a limited number of doses of the Pfizer/BioNTech vaccine in advance of their total allocated quota. A total of 72 countries from around the world submitted applications that were evaluated by an independent committee based on pandemic risk and impact criteria, mortality rates in recent weeks, as well as the number of doses available and the feasibility for immediate use by the countries.

The committee selected 18 countries globally, of which 4 are from the Americas region: Bolivia, Colombia, El Salvador and Peru. The total number of doses of Pfizer/BioNTech vaccine to be received by these 4 countries will be 377,910 and is expected to arrive from mid-February, subject to the establishment of UNICEF and PAHO supply agreements with the producer, according to COVAX.

“The Pan American Health Organization has accompanied and provided the necessary technical support to Member States to support them in each phase of their participation in the COVAX mechanism, in addition to the preparation of national vaccination plans for COVID-19,” said PAHO Deputy Director, Dr. Jarbas Barbosa.

The use of these vaccines will allow us to advance in the fight against this pandemic, but we must still maintain and strengthen public health measures – such as the use of masks, avoiding crowds, social distancing and frequent hand washing – to prevent transmission, increased cases and deaths as a result of COVID-19.”

Dr. Jarbas Barbosa

The PAHO Revolving Fund, together with UNICEF, are responsible for procuring all vaccines on behalf of the COVAX mechanism.

The Americas region will need to immunize approximately 500 million people to control the pandemic. The COVAX mechanism is a global effort to accelerate equitable access to COVID-19 vaccines and ensure that they reach all those who need them. It is the most effective option for equitable access to vaccines by countries and individuals, especially the most vulnerable populations.

The goal is to provide vaccines for at least 20% of the population in each country participating in the COVAX mechanism to protect those most at risk of severe forms of COVID-19. In Latin America and the Caribbean, 37 countries will receive vaccines through the COVAX mechanism, of which 27 will do so with their own funding and 10 will do so at no cost due to their economic condition or population size.

The Americas region will need to immunize approximately 500 million people to control the pandemic. The COVAX mechanism is a global effort to accelerate equitable access to COVID-19 vaccines and ensure that they reach all those who need them. It is the most effective option for equitable access to vaccines by countries and individuals, especially the most vulnerable populations.

The goal is to provide vaccines for at least 20% of the population in each country participating in the COVAX mechanism to protect those most at risk of severe forms of COVID-19. In Latin America and the Caribbean, 37 countries will receive vaccines through the COVAX mechanism, of which 27 will do so with their own funding and 10 will do so at no cost due to their economic condition or population size.

https://diariolahuella.com/ops-anuncia-que-el-salvador-ha-sido-seleccionado-para-recibir-vacunas-contra-covid-19-por-su-buen-nivel-de-preparacion/

PAHO ANNOUNCES THAT EL SALVADOR HAS BEEN SELECTED TO RECEIVE COVID-19 VACCINES DUE TO ITS GOOD LEVEL OF PREPAREDNESS

by Redaccion 02/01/2021 in https://diariolahuella.com/

Government to guarantee 100 vaccination centers when COVID-19 vaccine arrives in the country

Through an official statement, the Pan American Health Organization (PAHO/WHO) informed today that El Salvador has been selected to receive the Covid-19 vaccine from the COVAX mechanism.

According to PAHO, El Salvador is one of the first 18 countries in the world to receive the “First Wave” of vaccines.

PAHO authorities explained that 72 countries worldwide applied to COVAX at the beginning of January, which had to provide evidence of their level of preparedness to use a vaccine that requires ultra-low freezing.

However, after an exhaustive evaluation by an independent committee, El Salvador was selected as it met the strict requirements and demonstrated its readiness to receive and rapidly apply the vaccine.

Among the Latin American countries that will receive the vaccine are: El Salvador, Colombia, Bolivia and Peru.

In addition, PAHO expects that the vaccines will begin to be received in the first half of February and by the end of the month, it has been reported that the largest number of doses will begin to be received.

https://diario.elmundo.sv/el-salvador-recibira-primeras-vacunas-contra-covid-19-en-febrero-via-covax/

EL SALVADOR TO RECEIVE FIRST COVID-19 VACCINES IN FEBRUARY, VIA COVAX

The first batch will be destined to first line health workers.

Editorial Staff DEM

Sunday 31, January 2021 – 9:09 am https://diario.elmundo.sv/

El Salvador will be among the first four Latin American countries to receive the Covid-19 vaccine next February, as part of the first round of vaccine distribution through the COVAX mechanism, according to a report from the United Nations office in Bolivia.

According to the office, El Salvador is among the first countries in Latin America to receive vaccines under this public-private initiative that promotes equitable access to covid-19 vaccines worldwide, along with Bolivia, Colombia and Peru.

In the case of El Salvador, according to sources consulted by Diario El Mundo, an initial batch of 16 thousand doses of the Pfizer BioNTech vaccine for front-line health workers will be received free of charge, thanks to COVAX.  The health system has about 40 thousand workers.

COVAX’s goal is to finance up to 20% of the population in poor countries such as El Salvador.

This lot is independent of the bilateral contracts that the Salvadoran government has established with pharmaceutical companies for the acquisition of vaccines.  The government has announced the acquisition of two million doses from the pharmaceutical company AstraZeneca, the only one authorized so far in the country, but has also said that it is negotiating with other pharmaceutical companies, without giving details.

President Nayib Bukele said in November that El Salvador aims to obtain nine million doses of the covid-19 vaccine.

COVAX is a global partnership for the procurement and equitable distribution of COVID-19 vaccines. It is led by the Coalition for Epidemic Preparedness Innovation (CEPI), Gavi and the Pan American Health Organization (PAHO)/ World Health Organization (WHO), working in partnership with vaccine manufacturers, the United Nations Children’s Fund (UNICEF), the World Bank, civil society organizations and others. COVAX is one of the pillars of WHO’s comprehensive, global plan to defeat the virus through the use of diagnostics, therapies and vaccines.

The COVAX Facility offered countries the opportunity on January 6 to express their interest in accessing an initial limited volume of an ultra-cold-chain vaccine from Pfizer/BioNTech.

https://ultimahora.sv/el-salvador-recibira-este-dia-primer-lote-de-vacunas-contra-el-covid-19-de-aztrazeneca/

EL SALVADOR TO RECEIVE ITS FIRST BATCH OF COVID-19 VACCINE IN THE FIRST HALF OF FEBRUARY

LATEST NEWSFeb 02, 2021, 12:03 Pm

By Redacción UH https://ultimahora.sv/

The Pan American Health Organization (PAHO), informed that El Salvador will be one of the 4 countries to receive the first batches of the vaccine against COVID-19 starting in the first half of February.

El Salvador, Bolivia, Colombia and Peru will be the first four countries to benefit from the COVAX program, a coalition led by the World Health Organization (WHO) and GAVI. A total of 377,910 doses of COVID-19 vaccines created by Pfizer and BioNTech will be distributed, so Salvadorans will be better protected against the pandemic thanks to the efforts of the Government of President Nayib Bukele